Kyverna Therapeutics Therapy Delivers Sustained Relief in Rare Neurological Conditions Benzinga 5d Article paywall
Consensus recommendations published for CAR-T therapy in adult all Hematology Advisor 14:32 Tue, 15 Sep T-Cells Nature Pharma All sources
Kyverna’s stiff-person syndrome trial shows one-year durability Clinical Trials Arena 4d Kyverna Pharma All sources
Study identifies why some patients develop severe intestinal inflammation after CAR-T therapy ecancer 4d T-Cells Cancer Treatment Blood Cancer
In vivo CAR-T therapy transforms customized treatments into universal medicines News-Medical.Net 4d T-Cells China
Surat-based Anupam Rasayan completes ₹1,750-cr acquisition of 48.2% in Bliss GVS Pharma The Hindu Business Line 7h
